Clinical Approach to Confusion / Delirium
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of confusion and delirium
Delirium is one of the most common and serious conditions encountered in hospitalized patients, affecting approximately 10-30% of all hospitalized medical patients and up to 50-80% of patients in intensive care units. It is associated with increased mortality, prolonged hospital stays, higher healthcare costs, and long-term cognitive decline. Despite its prevalence and consequences, delirium remains underdiagnosed in up to 70% of cases, making recognition and systematic assessment essential skills for every clinician.
Definition
Delirium is an acute, fluctuating disturbance in attention, awareness, and cognition that develops over hours to days and represents a change from baseline. It is caused by an underlying medical condition, substance intoxication or withdrawal, medication effect, or a combination of factors. The term “acute confusional state” is often used synonymously with delirium.
Key Features (DSM-5 Criteria):
- Disturbance in attention and awareness
- Develops acutely (hours to days) and fluctuates in severity
- Additional cognitive disturbance (memory, orientation, language, perception)
- Not explained by a pre-existing or evolving neurocognitive disorder
- Evidence of an underlying medical cause
Key Epidemiology
- General medical wards: 10-30% prevalence
- Intensive care units: 50-80% prevalence
- Post-operative (major surgery): 15-53%
- Emergency department (elderly): 8-17%
- Mortality: 22-76% in hospitalized patients
- Missed diagnosis rate: Up to 70%
- Average length of stay increase: 5-10 days
- Long-term cognitive decline: 40% of survivors
Classification by Psychomotor Subtype
| Subtype | Prevalence | Clinical Features | Clinical Significance |
|---|---|---|---|
| Hyperactive Delirium | 25% | Agitation, restlessness, hypervigilance, hallucinations, combativeness, pulling at lines and tubes | Most easily recognized; often associated with substance withdrawal or medication toxicity; higher risk of falls and self-injury |
| Hypoactive Delirium | 25-50% | Lethargy, reduced motor activity, withdrawn behavior, slow speech, decreased awareness | Most commonly missed (often mistaken for depression or fatigue); associated with worse prognosis and higher mortality |
| Mixed Delirium | 35-45% | Fluctuating between hyperactive and hypoactive states, unpredictable behavior patterns | Most common subtype; fluctuating nature can delay diagnosis; requires frequent reassessment |
Classification by Duration and Course
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute Delirium | Hours to days | Infection, medication effects, metabolic derangements, acute organ failure, stroke | Requires urgent evaluation for reversible causes; higher mortality if untreated |
| Persistent Delirium | Weeks to months | Unresolved underlying cause, multiple contributing factors, pre-existing cognitive impairment | Associated with prolonged hospitalization and increased risk of institutionalization |
| Subsyndromal Delirium | Variable | Partial recovery from full delirium, prodromal phase, milder insults | May progress to full delirium; requires close monitoring; often represents incomplete recovery |
Distinguishing Delirium from Other Cognitive Disorders
| Feature | Delirium | Dementia | Depression |
|---|---|---|---|
| Onset | Acute (hours to days) | Insidious (months to years) | Weeks to months |
| Course | Fluctuating throughout the day | Progressive, relatively stable day-to-day | Diurnal variation (worse in morning) |
| Attention | Impaired (cardinal feature) | Usually preserved until late stages | Intact but may appear diminished |
| Consciousness | Altered (clouded or hyperalert) | Clear until very late stages | Clear |
| Hallucinations | Common (especially visual) | Less common, may occur in Lewy body dementia | Rare (if present, usually auditory) |
| Reversibility | Usually reversible if cause treated | Generally irreversible | Treatable and reversible |
Classification by Clinical Setting
Hospital-Acquired (Incident) Delirium
Develops during hospitalization in a patient who was cognitively intact on admission. Associated with iatrogenic factors including medications, sleep deprivation, immobility, and procedures. Prevention strategies can reduce incidence by 30-40%.
Community-Acquired (Prevalent) Delirium
Present on admission to hospital or emergency department. Often indicates serious underlying illness such as infection, stroke, or metabolic crisis. May be the primary presenting symptom in elderly patients with significant pathology.
The Two-Hit Model: Vulnerability and Insult
Key Concept: Delirium develops when a precipitating insult overwhelms a patient’s cognitive reserve. Patients with high vulnerability (multiple predisposing factors) may develop delirium from minor insults, while robust patients require severe precipitants. This explains why a simple urinary tract infection causes delirium in a frail elderly patient but not in a healthy young adult.
Predisposing Factors (Vulnerability)
- Age greater than 65 years — strongest risk factor
- Pre-existing cognitive impairment — dementia increases risk 2-5 fold
- Functional impairment — dependence in activities of daily living
- Sensory impairment — vision or hearing loss
- Multiple comorbidities — higher burden of chronic illness
- Malnutrition and dehydration
- History of alcohol use disorder
- History of prior delirium episodes
Precipitating Factors (Insults)
- Infections — urinary tract infection, pneumonia, sepsis
- Medications — anticholinergics, opioids, benzodiazepines
- Metabolic derangements — electrolyte abnormalities, hypoglycemia
- Hypoxia — respiratory failure, severe anemia
- Pain — undertreated or severe pain
- Urinary retention or fecal impaction
- Sleep deprivation
- Immobility and physical restraints
- Surgery and anesthesia
- Substance withdrawal — alcohol, benzodiazepines, opioids
Key Concept — “Delirium is a Medical Emergency”: Delirium should never be dismissed as “just confusion” or attributed solely to old age. It indicates that the brain is failing due to an underlying systemic insult, analogous to how elevated creatinine indicates kidney failure. The cause must be identified and treated urgently. In elderly patients, delirium may be the only presenting sign of serious illness such as myocardial infarction, sepsis, or stroke.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of delirium
Delirium represents a global failure of brain function resulting from disruption of normal neurotransmitter balance, neuroinflammation, oxidative stress, and impaired cerebral metabolism. The pathophysiology is multifactorial, and in most cases, multiple mechanisms operate simultaneously. Understanding these mechanisms helps explain why diverse insults produce a similar clinical syndrome and guides targeted treatment approaches.
The Four Core Mechanisms of Delirium
| Mechanism | Description | Clinical Relevance |
|---|---|---|
| Neurotransmitter Imbalance | Decreased acetylcholine and/or increased dopamine activity disrupting normal neural signaling | Explains why anticholinergic medications precipitate delirium and why cholinesterase inhibitors may be protective |
| Neuroinflammation | Systemic inflammation triggers microglial activation and neuroinflammatory cascades that disrupt neural function | Explains the strong association between infection, sepsis, and delirium |
| Oxidative Stress | Imbalance between reactive oxygen species production and antioxidant defenses damages neurons | Contributes to both acute dysfunction and potential long-term cognitive sequelae |
| Impaired Cerebral Metabolism | Decreased oxygen or glucose delivery, or inability to utilize substrates, impairs neuronal function | Explains delirium in hypoxia, hypoglycemia, hepatic encephalopathy, and uremia |
Neurotransmitter Pathways in Delirium
Acetylcholine Deficiency
Normal function: Essential for attention, memory, and arousal through cholinergic projections from the basal forebrain
In delirium: Reduced synthesis (hypoxia, thiamine deficiency) or receptor blockade (anticholinergic medications) impairs attention and cognition
Clinical relevance: Anticholinergic burden is a major modifiable risk factor; explains efficacy of physostigmine in anticholinergic toxicity
Dopamine Excess
Normal function: Modulates attention, motor activity, and reward through mesolimbic and mesocortical pathways
In delirium: Relative or absolute dopamine excess contributes to agitation, hallucinations, and psychomotor disturbance
Clinical relevance: Provides rationale for antipsychotic use in hyperactive delirium; explains delirium from dopaminergic medications
Other Neurotransmitters
GABA: Increased activity causes sedation (hepatic encephalopathy); decreased activity causes withdrawal delirium (alcohol, benzodiazepines)
Glutamate: Excessive activity leads to excitotoxicity; implicated in hypoxic injury
Serotonin: Excess causes serotonin syndrome with associated delirium; deficiency may contribute to hypoactive delirium
The Neuroinflammation Pathway
| Step | Process | Result |
|---|---|---|
| 1. Systemic Trigger | Infection, surgery, trauma, or other insult releases inflammatory mediators (interleukin-1, interleukin-6, tumor necrosis factor-alpha) | Systemic inflammatory response |
| 2. Blood-Brain Barrier Disruption | Cytokines increase blood-brain barrier permeability, allowing entry of peripheral immune signals | Loss of central nervous system protection |
| 3. Microglial Activation | Brain-resident immune cells (microglia) become activated and release neuroinflammatory mediators | Local neuroinflammation |
| 4. Neuronal Dysfunction | Inflammatory mediators impair synaptic function, alter neurotransmitter release, and disrupt neural networks | Clinical delirium manifestations |
| 5. Potential Neurodegeneration | Prolonged inflammation may cause neuronal death, particularly in vulnerable patients | Long-term cognitive impairment |
How Specific Conditions Cause Delirium
| Condition | Primary Mechanism | Treatment Implication |
|---|---|---|
| Infection and Sepsis | Systemic inflammation triggers neuroinflammation; cytokines impair neurotransmission; microvascular dysfunction reduces cerebral perfusion | Early source control and antimicrobials are essential; delirium resolution tracks with infection resolution |
| Anticholinergic Medications | Direct blockade of muscarinic acetylcholine receptors impairs cholinergic transmission essential for attention and memory | Discontinue or reduce anticholinergic medications; calculate anticholinergic burden |
| Hepatic Encephalopathy | Ammonia crosses blood-brain barrier, increases glutamine in astrocytes, causes cerebral edema; also increases GABAergic tone and manganese deposition | Lactulose to reduce ammonia; treat precipitants; rifaximin for recurrent episodes |
| Uremia | Accumulation of uremic toxins disrupts blood-brain barrier and impairs neurotransmitter function; metabolic acidosis contributes | Dialysis to remove uremic toxins; correct electrolyte and acid-base abnormalities |
| Hypoglycemia | Brain depends on glucose as primary fuel; hypoglycemia causes acute neuronal energy failure; prolonged hypoglycemia causes irreversible damage | Immediate glucose administration is critical; identify and treat underlying cause |
| Hypoxia | Decreased oxygen delivery impairs oxidative phosphorylation; neurons cannot maintain membrane potentials or neurotransmitter synthesis | Correct hypoxia; identify cause (pulmonary, cardiac, anemia) |
| Alcohol Withdrawal | Chronic alcohol causes GABA receptor downregulation and glutamate receptor upregulation; withdrawal removes GABA potentiation leading to neuronal hyperexcitability | Benzodiazepines to restore GABAergic inhibition; thiamine supplementation; adequate dosing is essential |
| Hyponatremia | Osmotic stress causes astrocyte swelling and cerebral edema; severity depends on rate of sodium decline | Gradual correction to avoid osmotic demyelination syndrome; more rapid correction if acute or symptomatic |
| Opioid Medications | Mu-opioid receptor activation affects multiple neurotransmitter systems; sedation and anticholinergic properties contribute | Use lowest effective dose; consider opioid-sparing strategies; avoid in vulnerable patients when possible |
| Post-operative State | Multifactorial: anesthetic effects, inflammation from surgical stress, pain, medications, sleep disruption, immobility | Multicomponent prevention; minimize sedation; early mobilization; pain control with opioid-sparing approaches |
Brain Regions and Networks Affected in Delirium
Key Structures
- Prefrontal cortex: Executive function and attention deficits
- Thalamus: Arousal and sensory gating disruption
- Basal forebrain: Cholinergic dysfunction affecting attention
- Hippocampus: Memory impairment
- Reticular activating system: Altered level of consciousness
Network Dysfunction
- Default mode network: Altered self-referential processing
- Frontoparietal network: Impaired attention and executive control
- Thalamocortical connectivity: Reduced integration of information
- Electroencephalography changes: Generalized slowing, reduced alpha rhythm
Why Delirium May Cause Long-Term Cognitive Harm
Delirium and Dementia: A Bidirectional Relationship
Delirium is not merely a transient state. Evidence suggests that delirium may accelerate cognitive decline and increase dementia risk through several mechanisms:
- Neuroinflammation: Persistent microglial activation may continue after clinical recovery
- Tau protein phosphorylation: Delirium may accelerate Alzheimer-type pathology
- Neuronal loss: Prolonged or severe delirium may cause irreversible neuronal death
- Synaptic dysfunction: Long-term changes in synaptic plasticity may persist
This underscores the importance of both prevention and early treatment of delirium.
Often Overlooked Mechanism: The Anticholinergic Burden
Many common medications have anticholinergic properties that are often unrecognized. When multiple medications with mild anticholinergic effects are combined, the cumulative “anticholinergic burden” can precipitate delirium, especially in elderly patients with reduced cholinergic reserve. Examples of medications with hidden anticholinergic activity include:
- Antihistamines: Diphenhydramine (commonly used for sleep), promethazine
- Antidepressants: Tricyclic antidepressants, paroxetine
- Antipsychotics: Chlorpromazine, olanzapine
- Urological agents: Oxybutynin, tolterodine
- Gastrointestinal agents: Hyoscine (scopolamine), dicyclomine
- Muscle relaxants: Cyclobenzaprine
Always calculate the anticholinergic burden when evaluating a delirious patient using tools such as the Anticholinergic Cognitive Burden Scale.
3. History Taking
A comprehensive approach to eliciting the delirium history
Red Flags — Require Urgent Evaluation
- Fever or hypothermia — sepsis, meningitis, encephalitis
- Focal neurological deficits — stroke, intracranial mass, abscess
- Severe headache or neck stiffness — meningitis, subarachnoid hemorrhage
- Seizure activity — status epilepticus, post-ictal state
- Recent head trauma — subdural hematoma, traumatic brain injury
- Oxygen saturation less than 90% — hypoxic encephalopathy
- Hypotension or shock — sepsis, cardiogenic shock, hypovolemia
- New-onset severe hypertension — hypertensive encephalopathy
- History of anticoagulation with confusion — intracranial hemorrhage
- Known or suspected poisoning or overdose — toxicological emergency
The Delirious Patient Cannot Provide Reliable History
By definition, patients with delirium have impaired attention and cognition. Collateral history is essential and must be obtained from:
- Family members or caregivers
- Nursing staff (for hospitalized patients)
- Emergency medical services personnel
- Previous medical records
- Pharmacy records for medication list
- Care facility staff (for nursing home residents)
Systematic History: The “DELIRIUM” Approach
Use the mnemonic “DELIRIUM” to ensure comprehensive history taking:
- D — Drugs and Substances: New medications? Recent changes? Alcohol or illicit drug use? Over-the-counter medications? Anticholinergic burden?
- E — Ears and Eyes: Sensory impairment? Are hearing aids and glasses available and in use?
- L — Low oxygen and metabolic states: Respiratory symptoms? Symptoms of anemia? Liver or kidney disease? Diabetes?
- I — Infection: Fever? Cough? Dysuria? Skin changes? Recent procedures or surgery?
- R — Retention (urinary or fecal): Last bowel movement? Urinary symptoms? Catheter in place?
- I — Ictal (seizures) and Intracranial: Witnessed seizure activity? Headache? Focal symptoms? Recent falls or head trauma?
- U — Undertreated pain: Sources of pain? Adequate analgesia? Nonverbal pain cues?
- M — Mental baseline and environment: What is their baseline cognition? Pre-existing dementia? Sleep deprivation? Recent move or hospitalization?
Establishing Cognitive Baseline
| Question to Ask Informant | What It Reveals | Why It Matters |
|---|---|---|
| “What was their mental state like before this started?” | Baseline cognition and function | Establishes whether this represents a change (required for delirium diagnosis) |
| “When did you first notice something was wrong?” | Acuity of onset | Acute onset (hours to days) suggests delirium; gradual onset suggests dementia |
| “Does the confusion come and go, or is it constant?” | Fluctuating course | Fluctuation is characteristic of delirium; stable confusion suggests other causes |
| “Do they have a diagnosis of dementia or memory problems?” | Pre-existing cognitive impairment | Dementia is the strongest risk factor for delirium; delirium can be superimposed on dementia |
| “Can they normally manage their own medications, finances, and daily activities?” | Functional baseline | Helps assess severity of change and baseline vulnerability |
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Urinary tract infection | Dysuria, frequency, foul-smelling urine, suprapubic pain | “Have they complained of burning with urination or needing to go frequently? Any change in urine smell?” |
| Pneumonia | Cough, sputum, dyspnea, fever | “Any cough, shortness of breath, or fever? Have they been less active or eating less?” |
| Medication-induced delirium | Recent medication change, anticholinergic drugs, opioids, sedatives | “Have any medications been started, stopped, or changed in the past two weeks? Any new over-the-counter medications or supplements?” |
| Alcohol withdrawal | History of heavy drinking, tremor, autonomic instability | “How much alcohol do they typically drink? When was their last drink? Have they ever had withdrawal symptoms or seizures?” |
| Benzodiazepine withdrawal | Chronic benzodiazepine use, recent discontinuation | “Do they take any sleeping pills or anti-anxiety medications regularly? Have these been stopped or reduced recently?” |
| Constipation or fecal impaction | Abdominal discomfort, reduced bowel movements | “When was their last bowel movement? Have they been eating and drinking normally?” |
| Urinary retention | Suprapubic fullness, decreased urine output, dribbling | “Have they been urinating normally? Any difficulty starting or a feeling of incomplete emptying?” |
| Pain | Grimacing, guarding, restlessness, history of painful conditions | “Do they have any conditions that cause pain? Have they been grimacing, guarding, or restless?” |
| Stroke or transient ischemic attack | Focal weakness, speech changes, visual disturbance | “Was there any sudden weakness, facial droop, or slurred speech? Any vision changes?” |
| Hypoglycemia | Diabetes, insulin or sulfonylurea use, missed meals | “Do they have diabetes? What medications do they take for it? Have they been eating normally?” |
| Subdural hematoma | Recent fall, anticoagulation, gradual onset | “Have they had any falls recently, even minor ones? Are they on blood thinners?” |
| Meningitis or encephalitis | Headache, fever, neck stiffness, photophobia | “Any severe headache, neck pain, or sensitivity to light? Any fever or rash?” |
Medication and Substance History
High-Risk Medications for Delirium
- Anticholinergics — diphenhydramine, oxybutynin, tricyclic antidepressants, first-generation antihistamines
- Benzodiazepines — especially long-acting agents (diazepam, clonazepam)
- Opioids — particularly meperidine, which has anticholinergic metabolites
- Corticosteroids — especially high doses
- Dopaminergic agents — levodopa, dopamine agonists
- Fluoroquinolones — ciprofloxacin, levofloxacin
- H2 blockers — famotidine, ranitidine
- Antipsychotics — paradoxical effects in some patients
- Anticonvulsants — phenytoin, valproate, levetiracetam
- Cardiac medications — digoxin, beta-blockers, antiarrhythmics
Substance Use and Withdrawal
- Alcohol: Quantify intake (drinks per day/week), last drink, prior withdrawal history, prior delirium tremens
- Benzodiazepines: Prescription or illicit use, duration, last dose
- Opioids: Prescription or illicit, route of use
- Cannabis: Heavy use can cause hyperemesis; withdrawal can cause irritability
- Stimulants: Cocaine, amphetamines (intoxication causes agitated delirium)
- Hallucinogens: Recent use, ongoing effects
Key Medication Questions
- What medications were recently started?
- What medications were recently stopped?
- Any dose changes in the past 2 weeks?
- Over-the-counter medications and supplements?
- Are they taking medications as prescribed?
Social, Environmental, and Functional History
| Domain | Key Questions | Relevance to Delirium |
|---|---|---|
| Living Situation | Lives alone? Nursing home? Family support? | Affects detection of early symptoms; living alone increases risk of dehydration, malnutrition, medication errors |
| Functional Status | Baseline mobility? Uses assistive devices? Independent in activities of daily living? | Functional impairment is a predisposing factor; immobility during illness worsens delirium |
| Sensory Aids | Uses glasses or hearing aids? Are they available? | Sensory deprivation worsens delirium; ensuring access to aids is therapeutic |
| Sleep Pattern | Normal sleep habits? Recent sleep deprivation? | Sleep disruption both precipitates and perpetuates delirium |
| Nutrition and Hydration | Recent oral intake? Signs of dehydration? | Malnutrition and dehydration are modifiable risk factors |
| Recent Changes | Recent hospitalization? Move to new environment? Loss of loved one? | Environmental change and psychosocial stress can precipitate delirium |
Constructing the Timeline
Essential Timeline Elements:
- Baseline: What was their cognitive function like 2 weeks ago? 1 month ago?
- First change: When was the first sign that something was different?
- Progression: Has it gotten worse, stayed stable, or fluctuated?
- Precipitant timing: What happened in the 48-72 hours before onset? (new medication, procedure, illness, fall)
- Associated symptoms: What other symptoms appeared around the same time?
4. Physical Examination
A systematic head-to-toe approach for the patient with confusion or delirium
Dual Purpose of Examination: The physical examination in a delirious patient serves two purposes: (1) confirming the presence of delirium using validated assessment tools, and (2) identifying the underlying cause through systematic evaluation. A complete examination is essential because the cause is often found outside the nervous system.
Cognitive Assessment: Confirming Delirium
The Confusion Assessment Method (CAM)
CAM Diagnostic Algorithm
Delirium is diagnosed when both of the following are present:
- Feature 1: Acute onset and fluctuating course
- Feature 2: Inattention
AND at least one of the following:
- Feature 3: Disorganized thinking
- Feature 4: Altered level of consciousness
Sensitivity: 94-100% | Specificity: 90-95%
Testing Attention (The Cardinal Feature)
| Test | How to Perform | Abnormal Result |
|---|---|---|
| Digit span forward | Ask patient to repeat a sequence of numbers (start with 3, increase to 7) | Unable to repeat 5 or more digits |
| Digit span backward | Ask patient to repeat numbers in reverse order | Unable to repeat 3 or more digits backward |
| Days of week backward | Ask patient to recite days of the week in reverse order starting from Sunday | Unable to complete or makes errors |
| Months of year backward | Ask patient to recite months in reverse order starting from December | Unable to complete or makes errors |
| Serial sevens | Ask patient to subtract 7 from 100 repeatedly | Unable to perform or multiple errors (less specific) |
| Spell WORLD backward | Ask patient to spell the word WORLD in reverse | Unable to complete correctly |
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Fever (greater than 38°C) or hypothermia (less than 36°C) | Infection, sepsis; hypothermia may indicate severe sepsis or hypothyroidism; elderly may not mount fever |
| Heart Rate | Tachycardia, bradycardia, irregularity | Tachycardia: infection, withdrawal, pain, hyperthyroidism; Bradycardia: heart block, hypothyroidism, medication effect |
| Blood Pressure | Hypotension, severe hypertension | Hypotension: sepsis, dehydration, bleeding; Severe hypertension: hypertensive encephalopathy, stroke |
| Respiratory Rate | Tachypnea, bradypnea, abnormal patterns | Tachypnea: pneumonia, pulmonary embolism, metabolic acidosis; Cheyne-Stokes: severe brain injury |
| Oxygen Saturation | Less than 90% indicates significant hypoxia | Hypoxia is a common and reversible cause of delirium; may be the only sign of pulmonary embolism |
| Blood Glucose | Less than 70 mg/dL or greater than 400 mg/dL | Hypoglycemia requires immediate treatment; severe hyperglycemia suggests diabetic ketoacidosis or hyperosmolar state |
General Inspection
Appearance and Behavior
- Level of arousal: Alert, drowsy, stuporous, or agitated
- Psychomotor activity: Increased (hyperactive), decreased (hypoactive), or fluctuating
- Affect: Anxious, fearful, apathetic, labile
- Attention: Easily distracted, difficulty maintaining conversation
- Speech: Incoherent, tangential, slow, pressured
- Nutritional status: Cachexia, obesity, muscle wasting
Signs of Specific Etiologies
- Tremor: Withdrawal (fine, high-frequency), hepatic encephalopathy (asterixis)
- Diaphoresis: Withdrawal, hypoglycemia, sepsis, thyrotoxicosis
- Pallor: Anemia, shock
- Jaundice: Hepatic encephalopathy
- Cyanosis: Hypoxia
- Signs of trauma: Head injury, falls
Head, Eyes, Ears, Nose, and Throat Examination
Head
- Scalp: Signs of trauma, surgical scars
- Face: Asymmetry suggesting stroke
- Temporal arteries: Tenderness (giant cell arteritis)
Eyes
- Pupils: Pinpoint (opioids), dilated (anticholinergics, sympathomimetics), asymmetric (intracranial pathology)
- Sclera: Icterus (liver disease)
- Conjunctivae: Pallor (anemia)
- Extraocular movements: Nystagmus (Wernicke encephalopathy), gaze deviation (stroke)
- Fundoscopy: Papilledema (raised intracranial pressure)
Ears and Nose
- Hearing: Impairment increases delirium risk
- Otoscopy: Otitis media, hemotympanum (basilar skull fracture)
- Battle sign: Mastoid bruising (basilar fracture)
- Raccoon eyes: Periorbital bruising (basilar fracture)
Mouth and Throat
- Mucous membranes: Dry (dehydration), cyanotic (hypoxia)
- Tongue: Dry, coated; lateral tongue biting (seizure)
- Dentition: Poor dental health (source of infection)
- Pharynx: Signs of infection
Neck Examination
- Neck stiffness: Meningitis, subarachnoid hemorrhage (perform with caution if trauma suspected)
- Thyroid: Enlarged (hyperthyroidism or hypothyroidism), tenderness (thyroiditis)
- Lymphadenopathy: Infection, malignancy
- Jugular venous pressure: Elevated (heart failure), low (dehydration)
- Carotid bruits: Cerebrovascular disease
Neurological Examination
Critical Point: Assess for Focal Neurological Deficits
Focal findings suggest structural brain lesion (stroke, hemorrhage, tumor, abscess) requiring urgent neuroimaging. Delirium from metabolic or toxic causes typically produces non-focal findings.
| Component | Assessment | Significance of Abnormalities |
|---|---|---|
| Cranial Nerves | Facial symmetry, pupil responses, extraocular movements, tongue deviation | Asymmetry suggests stroke or mass lesion; pupil abnormalities may indicate herniation or toxidrome |
| Motor | Strength in all four limbs, tone, drift | Focal weakness suggests stroke; increased tone may indicate neuroleptic malignant syndrome or serotonin syndrome |
| Reflexes | Deep tendon reflexes, plantar responses | Asymmetric reflexes suggest focal lesion; upgoing plantars indicate upper motor neuron pathology |
| Asterixis | Have patient hold arms outstretched with wrists dorsiflexed | Flapping tremor suggests metabolic encephalopathy (hepatic, uremic, hypercapnic) |
| Gait | Observe if safe to assess | Ataxia: Wernicke encephalopathy, intoxication, cerebellar lesion |
| Tremor | Character, frequency, distribution | Fine tremor: withdrawal, thyrotoxicosis; Coarse tremor: parkinsonism, medication effect |
| Meningeal Signs | Neck stiffness, Kernig sign, Brudzinski sign | Meningitis, subarachnoid hemorrhage (may be absent in elderly or immunocompromised) |
Cardiovascular Examination
- Heart sounds: Murmurs (endocarditis), irregularity (atrial fibrillation with embolic stroke)
- Peripheral pulses: Weak (shock), asymmetric (vascular disease)
- Peripheral edema: Heart failure, venous thrombosis
- Capillary refill: Prolonged in shock states
Respiratory Examination
- Respiratory pattern: Kussmaul breathing (metabolic acidosis), Cheyne-Stokes (severe brain injury)
- Breath sounds: Crackles (pneumonia, pulmonary edema), decreased sounds (effusion, consolidation)
- Work of breathing: Accessory muscle use, nasal flaring (respiratory failure)
Abdominal Examination
- Distension: Ascites (hepatic encephalopathy), urinary retention, bowel obstruction
- Tenderness: Cholecystitis, appendicitis, peritonitis
- Hepatomegaly: Liver disease, heart failure
- Splenomegaly: Infection, malignancy
- Bladder palpation: Urinary retention (palpable suprapubic mass)
- Bowel sounds: Absent (ileus), hyperactive (obstruction)
- Rectal examination: Fecal impaction, melena, masses
Skin Examination
| Finding | Description | Suggests |
|---|---|---|
| Jaundice | Yellow discoloration of skin and sclera | Hepatic encephalopathy, biliary obstruction |
| Spider angiomata | Small vascular lesions with central red spot | Chronic liver disease |
| Petechiae or purpura | Small hemorrhages in skin | Meningococcemia, thrombocytopenia, disseminated intravascular coagulation |
| Cellulitis or abscess | Localized erythema, warmth, swelling | Infection source for sepsis |
| Pressure ulcers | Skin breakdown over bony prominences | Potential infection source; indicates immobility |
| Track marks | Needle marks over veins | Intravenous drug use |
| Diaphoresis | Excessive sweating | Withdrawal, hypoglycemia, sepsis, autonomic instability |
| Dry skin and decreased turgor | Tenting of skin when pinched | Dehydration |
Expected Findings by Etiology
| Condition | Vital Signs | Key Physical Findings | Neurological Examination |
|---|---|---|---|
| Sepsis | Fever or hypothermia, tachycardia, hypotension, tachypnea | Source of infection (lungs, skin, urine), poor perfusion | Non-focal, may have asterixis |
| Alcohol withdrawal | Tachycardia, hypertension, fever | Tremor, diaphoresis, agitation | Non-focal, fine tremor, may have seizures |
| Hepatic encephalopathy | May be normal or have signs of hepatorenal syndrome | Jaundice, ascites, spider angiomata, fetor hepaticus | Asterixis, non-focal, may progress to coma |
| Stroke | May have hypertension, atrial fibrillation | May be minimal if posterior circulation | Focal deficits: hemiparesis, facial droop, aphasia, gaze deviation |
| Wernicke encephalopathy | Often normal | Malnutrition, signs of alcohol use disorder | Classic triad: confusion, ataxia, ophthalmoplegia (often incomplete) |
| Anticholinergic toxicity | Tachycardia, fever | Dry skin, flushed, urinary retention, decreased bowel sounds | Dilated pupils, agitation, picking at air, mumbling speech |
| Opioid toxicity | Bradypnea, hypotension | Track marks (if intravenous use) | Pinpoint pupils, decreased consciousness, hypoactive |
| Hypoglycemia | Tachycardia, diaphoresis | Diaphoresis, pallor | Variable: may have focal signs mimicking stroke |
| Meningitis | Fever, tachycardia | Petechial rash (meningococcal), photophobia | Neck stiffness, Kernig and Brudzinski signs, non-focal |
| Urinary tract infection (in elderly) | May have fever or be afebrile | Suprapubic tenderness, foul-smelling urine | Non-focal |
Important Teaching Point
The examination may be entirely normal! Many causes of delirium, including urinary tract infection in the elderly, early sepsis, medication effects, and metabolic derangements, may present with entirely normal physical examination findings aside from the cognitive assessment. A normal examination does not exclude serious underlying pathology — laboratory investigations and imaging are often required to identify the cause.
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
The differential diagnosis of delirium is broad because it represents a final common pathway of brain dysfunction from many different insults. The key is to systematically consider all potential causes, recognizing that multiple etiologies often coexist in a single patient. A structured approach using the mnemonic and probability-based thinking helps ensure no cause is overlooked.
Etiological Framework: “I WATCH DEATH”
Use the mnemonic “I WATCH DEATH” to systematically consider all causes of delirium:
- I — Infection: Urinary tract infection, pneumonia, sepsis, meningitis, encephalitis
- W — Withdrawal: Alcohol, benzodiazepines, opioids, barbiturates
- A — Acute metabolic: Electrolyte abnormalities, acidosis, alkalosis, hepatic or renal failure
- T — Trauma: Head injury, subdural hematoma, post-operative state
- C — Central nervous system pathology: Stroke, hemorrhage, tumor, seizure, encephalitis
- H — Hypoxia: Respiratory failure, carbon monoxide poisoning, severe anemia
- D — Deficiencies: Thiamine (Wernicke), vitamin B12, folate
- E — Endocrinopathies: Thyroid disorders, adrenal crisis, hypoglycemia, hyperglycemia
- A — Acute vascular: Stroke, hypertensive encephalopathy, vasculitis
- T — Toxins and drugs: Medications, illicit drugs, poisons, heavy metals
- H — Heavy metals and other: Lead, mercury; also urinary retention, fecal impaction, pain
Differential Diagnosis by Probability
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 70%) | Infection (urinary tract infection, pneumonia, sepsis) | Fever (may be absent in elderly), localizing symptoms, elevated white blood cell count | Hypotension, tachycardia, altered mental status |
| Medication-induced delirium | Recent medication change, anticholinergic or sedative drugs, polypharmacy | Symptoms correlate with drug initiation or dose change | |
| Metabolic derangements | Electrolyte abnormalities (sodium, calcium), renal failure, hepatic failure | Severe hyponatremia, asterixis, known organ failure | |
| Dehydration and poor nutrition | Decreased oral intake, dry mucous membranes, concentrated urine | Hypotension, tachycardia, acute kidney injury | |
| Urinary retention | Suprapubic fullness, decreased urine output, history of prostatic disease | Complete obstruction, acute kidney injury | |
| Fecal impaction | Constipation history, abdominal distension, overflow diarrhea | Bowel obstruction, fecal peritonitis | |
| Pain (undertreated) | Known painful condition, nonverbal pain cues, inadequate analgesia | May mask serious underlying pathology | |
| Post-operative delirium | Occurs 24-72 hours post-surgery, more common after major procedures | Prolonged or severe cases may indicate complications | |
| LESS COMMON (approximately 20%) | Alcohol withdrawal | History of heavy drinking, tremor, autonomic instability, 48-96 hours after last drink | Seizures, severe hypertension, hyperthermia (delirium tremens) |
| Hypoglycemia | Diabetes, insulin or sulfonylurea use, missed meals, diaphoresis | Blood glucose less than 50 mg/dL, seizures, coma | |
| Hypoxia or hypercapnia | Respiratory disease, low oxygen saturation, cyanosis | Severe hypoxia (oxygen saturation less than 85%), respiratory failure | |
| Stroke (especially posterior circulation) | Sudden onset, focal deficits (may be subtle), vascular risk factors | Acute onset, focal neurological signs, basilar artery territory | |
| Subdural hematoma | Recent fall (even minor), anticoagulation, gradual onset, headache | Focal deficits, declining consciousness, anticoagulant use | |
| Benzodiazepine or opioid withdrawal | Chronic use of sedatives or opioids, recent discontinuation | Seizures, severe autonomic instability | |
| UNCOMMON BUT SERIOUS (approximately 10%) | Meningitis or encephalitis | Headache, fever, neck stiffness, photophobia | Fever with altered mental status, petechial rash, immunocompromised |
| Status epilepticus (non-convulsive) | History of seizures, subtle motor signs, fluctuating consciousness | Prolonged altered mental status, subtle eye or facial twitching | |
| Wernicke encephalopathy | Alcohol use disorder, malnutrition, classic triad (often incomplete) | Ophthalmoplegia, ataxia — requires immediate thiamine | |
| Hypertensive encephalopathy | Severe hypertension (often greater than 180/120), headache, visual changes | Papilledema, seizures, posterior reversible encephalopathy syndrome | |
| Thyroid storm or myxedema coma | Known thyroid disease, extreme vital sign abnormalities | Hyperthermia and tachycardia (storm) or hypothermia and bradycardia (myxedema) | |
| Adrenal crisis | Known adrenal insufficiency, recent steroid discontinuation, hypotension | Refractory hypotension, hyponatremia, hyperkalemia | |
| Serotonin syndrome | Serotonergic medications, hyperthermia, rigidity, clonus | Hyperthermia, severe rigidity, autonomic instability | |
| Neuroleptic malignant syndrome | Recent antipsychotic use, hyperthermia, severe rigidity (“lead pipe”) | Hyperthermia, severe rigidity, elevated creatine kinase |
Anatomical and System-Based Approach
Central Nervous System
Stroke (ischemic or hemorrhagic)
Subdural or epidural hematoma
Meningitis or encephalitis
Brain tumor or abscess
Seizures or post-ictal state
Normal pressure hydrocephalus
Infectious Sources
Urinary tract infection
Pneumonia
Skin or soft tissue infection
Intra-abdominal infection
Endocarditis
Sepsis (any source)
Metabolic and Endocrine
Hyponatremia or hypernatremia
Hypercalcemia or hypocalcemia
Hypoglycemia or hyperglycemia
Uremia (renal failure)
Hepatic encephalopathy
Thyroid disorders
Adrenal insufficiency
Toxic and Drug-Related
Anticholinergic medications
Opioids and sedatives
Alcohol intoxication or withdrawal
Benzodiazepine withdrawal
Serotonin syndrome
Neuroleptic malignant syndrome
Carbon monoxide poisoning
Drug-Induced Delirium
| Drug or Drug Class | Mechanism | Characteristics | Time to Resolution After Stopping |
|---|---|---|---|
| Anticholinergics (diphenhydramine, oxybutynin, tricyclics) | Muscarinic receptor blockade reduces acetylcholine signaling | Dry skin, urinary retention, dilated pupils, tachycardia, picking at air | 24-72 hours (longer for agents with long half-lives) |
| Benzodiazepines (diazepam, lorazepam, alprazolam) | GABA potentiation causes sedation; paradoxical reactions in elderly | Sedation, ataxia, slurred speech; or paradoxical agitation | 1-7 days depending on half-life |
| Opioids (morphine, oxycodone, fentanyl) | Mu-receptor activation; metabolites may be neurotoxic (meperidine) | Sedation, pinpoint pupils, respiratory depression; myoclonus with meperidine | 24-72 hours (longer for methadone) |
| Corticosteroids (prednisone, dexamethasone) | Multiple mechanisms including effects on neurotransmitters and glucose | Agitation, insomnia, euphoria, or depression; dose-dependent | Days to weeks after discontinuation |
| Fluoroquinolones (ciprofloxacin, levofloxacin) | GABA antagonism and possible direct neurotoxicity | Agitation, confusion, seizures; more common in elderly | 24-72 hours after stopping |
| H2-receptor antagonists (famotidine, ranitidine) | Central histamine receptor effects; accumulates in renal impairment | Confusion, particularly in elderly or renal impairment | 24-48 hours |
| Dopaminergic agents (levodopa, pramipexole, ropinirole) | Excess dopamine causes psychosis and agitation | Visual hallucinations, paranoia, agitation | Days to weeks (gradual taper may be needed) |
| Digoxin | Sodium-potassium ATPase inhibition; visual cortex effects | Confusion, visual disturbances (yellow-green halos), nausea | Days to weeks (long half-life) |
| Anticonvulsants (phenytoin, valproate, levetiracetam) | Various mechanisms; toxicity or idiosyncratic reactions | Sedation, ataxia, confusion; check drug levels | Variable; depends on drug and indication |
| Lithium | Neurotoxicity from elevated levels; narrow therapeutic window | Tremor, ataxia, confusion, seizures | Days (may need dialysis if severe) |
Special Consideration: Delirium Superimposed on Dementia
Delirium Can Occur in Patients with Dementia
Patients with pre-existing dementia are at highest risk for delirium and frequently develop it during illness or hospitalization. Key points:
- Do not assume worsening is “just dementia” — acute changes always warrant evaluation for delirium
- Collateral history is essential — establish what baseline cognition was
- The same causes apply — infection, medications, metabolic derangements
- Presentation may be more subtle — hypoactive delirium is more common
- Recovery may be incomplete — delirium may accelerate cognitive decline
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Tremor, tachycardia, hypertension, diaphoresis | Alcohol or sedative withdrawal | Obtain substance use history; initiate benzodiazepine protocol if indicated |
| Fever with confusion | Infection (sepsis, meningitis, urinary tract infection, pneumonia) | Blood cultures, urinalysis, chest radiograph; consider lumbar puncture |
| Focal neurological deficit | Stroke, intracranial hemorrhage, mass lesion | Urgent computed tomography of head |
| Asterixis (flapping tremor) | Metabolic encephalopathy (hepatic, uremic, hypercapnic) | Check liver function, ammonia, creatinine, blood gas |
| Jaundice with confusion | Hepatic encephalopathy | Ammonia level, liver function tests; look for precipitants |
| Ophthalmoplegia and ataxia | Wernicke encephalopathy | Give thiamine immediately before glucose |
| Pinpoint pupils, bradypnea | Opioid toxicity | Administer naloxone |
| Dilated pupils, dry skin, urinary retention | Anticholinergic toxicity | Review medication list; consider physostigmine if severe |
| Hyperthermia, rigidity, altered mental status | Neuroleptic malignant syndrome or serotonin syndrome | Check creatine kinase; stop offending agents; supportive care |
| Recent fall with anticoagulation | Subdural hematoma | Computed tomography of head; check coagulation studies |
| Post-operative day 1-3 | Post-operative delirium | Review medications; check for infection, urinary retention, pain |
| Elderly with “just a urinary tract infection” | Urinary tract infection (but consider other causes too) | Treat infection but continue looking for other contributors |
Clinical Pearl: Multiple Causes Are Common
In most cases of delirium, multiple contributing factors are present. Studies show that the average delirious patient has 2-6 contributing causes. Finding one cause should not stop the search for others. A patient may have a urinary tract infection AND be on anticholinergic medications AND be dehydrated AND sleep-deprived. Addressing all contributing factors improves outcomes.
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
The investigation of delirium should be systematic and guided by clinical findings, but a baseline set of investigations is warranted in virtually all patients because the cause is often not apparent from history and examination alone. The goal is to identify reversible causes while avoiding unnecessary testing.
Baseline Investigations for All Patients
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete blood count | Screen for infection, anemia, hematological disorders | Leukocytosis or leukopenia (infection), anemia (hypoxia), thrombocytopenia | Elderly may not mount leukocytosis; left shift may be more sensitive |
| Basic metabolic panel | Identify electrolyte abnormalities and renal dysfunction | Sodium (less than 125 or greater than 150 mEq/L critical), potassium, glucose, creatinine, blood urea nitrogen | Calculate corrected sodium if hyperglycemic; check for acute kidney injury |
| Blood glucose | Rule out hypoglycemia or severe hyperglycemia | Less than 70 mg/dL (hypoglycemia) or greater than 400 mg/dL (diabetic ketoacidosis or hyperosmolar state) | Point-of-care glucose should be obtained immediately in all patients |
| Urinalysis | Screen for urinary tract infection | Pyuria, bacteriuria, nitrites, leukocyte esterase | Asymptomatic bacteriuria is common in elderly; correlate with clinical picture |
| Chest radiograph | Screen for pneumonia, heart failure, mass lesions | Infiltrates, cardiomegaly, pleural effusions | May be normal early in pneumonia; clinical suspicion should guide treatment |
| Electrocardiogram | Identify arrhythmias, ischemia, QTc prolongation | Arrhythmias, ST changes, prolonged QTc (important if using antipsychotics) | Silent myocardial infarction can present as delirium in elderly |
| Oxygen saturation or arterial blood gas | Assess oxygenation and ventilation | Hypoxia (less than 90%), hypercapnia (greater than 50 mmHg), acidosis | Pulse oximetry is sufficient for screening; blood gas if respiratory concerns |
| Liver function tests | Screen for hepatic dysfunction | Elevated transaminases, bilirubin, decreased albumin | May indicate hepatic encephalopathy; check ammonia if abnormal |
| Calcium (corrected for albumin) | Screen for hypercalcemia or hypocalcemia | Corrected calcium greater than 12 mg/dL or less than 8 mg/dL | Hypercalcemia is an often-overlooked cause of confusion |
Additional Baseline Tests (Based on Clinical Context)
| Investigation | When to Order | What to Look For |
|---|---|---|
| Thyroid-stimulating hormone | All elderly patients; known thyroid disease; suggestive symptoms | Elevated (hypothyroidism) or suppressed (hyperthyroidism) |
| Ammonia level | Known liver disease; asterixis on examination; unexplained encephalopathy | Elevated level supports hepatic encephalopathy (but can be normal) |
| Blood cultures | Fever; suspected sepsis; no clear source of infection | Positive cultures guide antibiotic therapy |
| Urine culture | Abnormal urinalysis; suspected urinary tract infection | Identifies organism and sensitivities |
| Drug levels | Patients on digoxin, lithium, phenytoin, valproate, theophylline | Supratherapeutic or toxic levels |
| Urine drug screen | Suspected intoxication or withdrawal; unknown history | Presence of substances; note that some drugs not detected on standard screens |
| Blood alcohol level | Suspected intoxication or withdrawal; altered mental status of unclear cause | Elevated level; low or zero level in suspected withdrawal |
| Vitamin B12 level | Macrocytic anemia; peripheral neuropathy; prolonged poor nutrition | Less than 200 pg/mL suggests deficiency |
| Cortisol level (random or stimulated) | Hypotension; known adrenal insufficiency; chronic steroid use | Low random cortisol (less than 10 mcg/dL in stressed patient suggests insufficiency) |
Targeted Investigations by Suspected Etiology
If Suspecting Central Nervous System Pathology
First-Line Tests
- Computed tomography (CT) of head without contrast: First-line imaging; detects hemorrhage, large infarcts, masses, hydrocephalus; available emergently
- Indications for urgent CT: Focal neurological deficits, recent head trauma, anticoagulation, declining consciousness, new severe headache
Second-Line Tests
- Magnetic resonance imaging (MRI) of brain: Superior for posterior circulation strokes, encephalitis, early ischemia, small lesions
- Lumbar puncture: If meningitis or encephalitis suspected (fever, headache, neck stiffness); perform after CT if focal signs present
- Electroencephalogram (EEG): If non-convulsive status epilepticus suspected; also useful for confirming delirium versus other states
If Suspecting Infection and Sepsis
First-Line Tests
- Complete blood count with differential: Leukocytosis, bandemia, or leukopenia
- Lactate level: Greater than 2 mmol/L suggests tissue hypoperfusion
- Procalcitonin: Elevated in bacterial infection; helps distinguish bacterial from viral
- Blood cultures (two sets): Before antibiotics if possible
- Urinalysis and urine culture: Common source in elderly
- Chest radiograph: Pneumonia screening
Second-Line Tests
- CT of chest, abdomen, pelvis: If no source identified and high suspicion
- Lumbar puncture: If meningitis suspected (may be indicated even without classic signs in elderly)
- Echocardiogram: If endocarditis suspected (new murmur, bacteremia, risk factors)
- CT or ultrasound of specific areas: Biliary source, abscess, soft tissue infection
If Suspecting Metabolic or Endocrine Cause
Electrolyte and Metabolic Tests
- Comprehensive metabolic panel: Sodium, potassium, calcium, magnesium, phosphorus, glucose, renal function
- Osmolality (serum and urine): For sodium disorders; calculate osmolar gap if toxic ingestion suspected
- Arterial blood gas: Acid-base status, CO2 level
- Ammonia level: Hepatic encephalopathy
Endocrine Tests
- Thyroid-stimulating hormone and free T4: Hypo- or hyperthyroidism
- Random cortisol or cosyntropin stimulation test: Adrenal insufficiency
- Glucose and hemoglobin A1c: Diabetes control
- Parathyroid hormone: If hypercalcemia present
If Suspecting Toxicological Cause
Screening Tests
- Urine drug screen: Detects many common drugs of abuse
- Blood alcohol level: Intoxication or withdrawal
- Acetaminophen and salicylate levels: Screen for common ingestions
- Serum osmolality and osmolar gap: Toxic alcohols (methanol, ethylene glycol)
Specific Drug Levels
- Digoxin level: Therapeutic range 0.5-2.0 ng/mL; toxicity often above 2.0 ng/mL
- Lithium level: Therapeutic 0.6-1.2 mEq/L; toxicity above 1.5 mEq/L
- Phenytoin level: Therapeutic 10-20 mcg/mL
- Valproic acid level: Therapeutic 50-100 mcg/mL
- Theophylline level: Therapeutic 10-20 mcg/mL
- Carboxyhemoglobin: If carbon monoxide poisoning suspected
When to Perform Lumbar Puncture
Indications for Lumbar Puncture in Delirium
- Fever with altered mental status and no clear source
- Meningeal signs (neck stiffness, photophobia) — may be absent in elderly
- Immunocompromised patient with fever and confusion
- Concern for herpes simplex encephalitis (fever, temporal lobe findings)
- Subacute or chronic confusion with no other explanation
- Suspected subarachnoid hemorrhage with negative CT
Obtain CT head before lumbar puncture if: Focal neurological deficits, papilledema, decreased consciousness, immunocompromised state, history of central nervous system disease, new seizure
When to Obtain Neuroimaging
| Indication | Urgency | Preferred Modality |
|---|---|---|
| Focal neurological deficits | EMERGENT | CT head without contrast (consider CT angiography if stroke suspected) |
| Declining level of consciousness | EMERGENT | CT head without contrast |
| Recent head trauma or fall | EMERGENT | CT head without contrast |
| Anticoagulation with new confusion | EMERGENT | CT head without contrast |
| Suspected meningitis or encephalitis | URGENT | CT before lumbar puncture; MRI if encephalitis suspected |
| No clear cause after initial workup | SEMI-URGENT | CT or MRI depending on clinical suspicion |
| Clear reversible cause identified (e.g., urinary tract infection, medication) | NOT ROUTINELY NEEDED | Consider if no improvement with treatment |
When to Order Electroencephalogram (EEG)
Strong Indications
- Suspected non-convulsive status epilepticus (fluctuating consciousness, subtle motor signs)
- Witnessed seizure activity with prolonged post-ictal confusion
- Unexplained coma or stupor
Consider EEG When
- Diagnosis of delirium is uncertain (differentiate from psychiatric conditions)
- No improvement despite treating identified causes
- Episodic behavioral changes suggesting seizures
Stepwise Investigation Algorithm
Recommended Sequence:
- Immediate (all patients): Point-of-care glucose, oxygen saturation, vital signs
- Within 1 hour: Complete blood count, basic metabolic panel, urinalysis, chest radiograph, electrocardiogram
- Based on clinical findings: Liver function tests, ammonia, thyroid-stimulating hormone, blood cultures, drug levels
- If focal signs or high-risk features: CT head (emergent)
- If fever and no source: Consider lumbar puncture (after CT if indicated)
- If no cause found or no improvement: MRI brain, EEG, expanded metabolic and toxicological workup
Investigation Pitfall: Over-Reliance on Normal Results
Normal investigation results do not exclude serious causes of delirium:
- Normal CT head does not exclude early ischemic stroke, encephalitis, or posterior circulation events
- Normal urinalysis does not exclude urinary tract infection in elderly (low sensitivity)
- Normal white blood cell count does not exclude infection in elderly or immunocompromised
- Normal ammonia level does not exclude hepatic encephalopathy
Clinical judgment must guide further investigation even when initial tests are normal.
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Airway compromise, severe respiratory distress, or oxygen saturation less than 88% | EMERGENT | Secure airway, provide supplemental oxygen, prepare for intubation if needed |
| Hemodynamic instability (systolic blood pressure less than 90 mmHg, signs of shock) | EMERGENT | Intravenous access, fluid resuscitation, vasopressors if needed, identify source |
| Blood glucose less than 60 mg/dL | EMERGENT | Administer dextrose (25-50 mL of 50% dextrose intravenously) immediately |
| Suspected opioid overdose (pinpoint pupils, bradypnea, unresponsive) | EMERGENT | Administer naloxone 0.4-2 mg intravenously; repeat as needed; support ventilation |
| Focal neurological deficits suggesting stroke | EMERGENT | Activate stroke protocol, emergent CT head, time of onset critical |
| Suspected meningitis (fever, neck stiffness, altered mental status) | EMERGENT | Blood cultures, empiric antibiotics (do not delay for lumbar puncture), dexamethasone |
| Suspected alcohol withdrawal with autonomic instability or seizures | URGENT | Benzodiazepines (symptom-triggered protocol), thiamine before glucose, close monitoring |
| Severe agitation posing danger to self or staff | URGENT | Verbal de-escalation first; pharmacological management if needed; identify cause |
| New confusion in patient on anticoagulation | URGENT | CT head to rule out intracranial hemorrhage; check coagulation studies |
| Fever with confusion but hemodynamically stable | URGENT | Sepsis workup, empiric antibiotics after cultures, identify source |
| New confusion with clear precipitant (e.g., new medication, urinary tract infection) | ROUTINE | Address precipitant, supportive care, monitor for improvement |
| Gradual worsening of baseline dementia without acute features | ROUTINE | Still evaluate for delirium; may need outpatient workup for dementia progression |
Step 2: Initial Stabilization and Safety
The “ABCs” of Delirium Management:
- Airway, Breathing, Circulation: Ensure adequate oxygenation and perfusion
- Blood glucose: Check immediately in all patients — treat hypoglycemia empirically if cannot obtain
- Consider thiamine: Give thiamine 100-500 mg intravenously before glucose if Wernicke encephalopathy possible
- Discontinue offending medications: Review medication list and stop high-risk drugs
- Ensure safety: Fall precautions, 1:1 observation if needed, avoid restraints if possible
Step 3: Systematic Diagnostic Approach
First Hour
- Confirm delirium (CAM)
- Point-of-care glucose
- Vital signs with oxygen saturation
- Brief focused examination
- Review medication list
- Collateral history
Within 4 Hours
- Complete blood count
- Basic metabolic panel
- Urinalysis
- Chest radiograph
- Electrocardiogram
- Liver function tests
Based on Findings
- CT head (if indicated)
- Blood cultures
- Lumbar puncture
- Drug levels
- Ammonia, thyroid-stimulating hormone
- Toxicology screen
Step 4: Management by Clinical Presentation
Algorithm A: Hyperactive Delirium (Agitated Patient)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Tremor, diaphoresis, tachycardia, hypertension, history of alcohol use | Alcohol withdrawal | Benzodiazepines (symptom-triggered); thiamine; monitor with CIWA-Ar scale |
| Dilated pupils, dry skin, urinary retention, recent anticholinergic medication | Anticholinergic toxicity | Stop offending agent; supportive care; consider physostigmine if severe |
| Hyperthermia, rigidity, recent antipsychotic use | Neuroleptic malignant syndrome | Stop antipsychotic; cooling measures; consider bromocriptine or dantrolene |
| Hyperthermia, clonus, hyperreflexia, serotonergic medications | Serotonin syndrome | Stop serotonergic agents; supportive care; consider cyproheptadine |
| Agitation with no clear toxidrome, stable vital signs | Delirium (various causes) | Non-pharmacological measures first; low-dose antipsychotic if needed for safety |
Algorithm B: Hypoactive Delirium (Lethargic Patient)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Pinpoint pupils, bradypnea, known opioid use | Opioid toxicity | Naloxone; support ventilation; identify source of opioids |
| Jaundice, asterixis, history of liver disease | Hepatic encephalopathy | Lactulose; identify precipitant (infection, gastrointestinal bleeding, constipation) |
| Hypothermia, bradycardia, delayed relaxation of reflexes | Myxedema coma | Intravenous levothyroxine and hydrocortisone; supportive care |
| Elderly patient on multiple sedating medications | Medication-induced delirium | Reduce or discontinue sedating medications; supportive care |
| Subtle eye twitching, history of seizures, no clear precipitant | Non-convulsive status epilepticus | Urgent electroencephalogram; anticonvulsant therapy if confirmed |
Algorithm C: Delirium with Fever
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Fever, dysuria, suprapubic tenderness, pyuria | Urinary tract infection | Urine culture; empiric antibiotics; ensure bladder drainage |
| Fever, cough, hypoxia, infiltrate on chest radiograph | Pneumonia | Blood and sputum cultures; empiric antibiotics per guidelines |
| Fever, neck stiffness, headache, photophobia | Meningitis | Emergent lumbar puncture (CT first if indicated); empiric antibiotics immediately |
| Fever, hypotension, tachycardia, no clear source | Sepsis | Aggressive fluid resuscitation; broad-spectrum antibiotics; source identification |
| Fever, focal neurological signs, altered behavior | Encephalitis | MRI brain; lumbar puncture; empiric acyclovir for herpes simplex encephalitis |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient becomes acutely agitated and combative | Ensure safety of patient and staff; verbal de-escalation; remove environmental triggers | If pharmacotherapy needed: haloperidol 0.5-2 mg or quetiapine 25-50 mg; avoid benzodiazepines unless withdrawal |
| Patient is pulling at intravenous lines and tubes | Address underlying cause (pain, urinary retention, discomfort); reorient; 1:1 supervision | Avoid physical restraints if possible; consider mittens; low-dose antipsychotic if needed |
| Delirium is not improving after 48-72 hours of treatment | Reassess for missed or additional causes; review medication list again | Consider neuroimaging if not done; EEG to rule out non-convulsive seizures; expand workup |
| Family is distressed by patient’s confusion and behavior | Educate family about delirium; explain it is usually reversible; involve them in non-pharmacological care | Regular updates; consider family presence at bedside for reorientation; address their questions |
| Patient refuses medications and investigations | Assess capacity (usually impaired in delirium); act in patient’s best interest | Document capacity assessment; involve family or surrogate decision-maker; prioritize essential interventions |
| Uncertain if this is delirium, dementia, or psychiatric illness | Assume delirium until proven otherwise; obtain collateral history about baseline | Use CAM criteria; look for fluctuation and acute onset; EEG can help differentiate |
| Patient has known dementia and is now more confused | This is likely delirium superimposed on dementia; full delirium workup is indicated | Do not attribute to dementia alone; treat reversible causes aggressively |
| Baseline investigations are all normal | Normal results do not exclude delirium causes; clinical judgment guides further testing | Consider CT/MRI head, lumbar puncture, EEG, medication review, occult infection sources |
Non-Pharmacological Management (First-Line for All Patients)
Essential Non-Pharmacological Interventions
- Reorientation: Clock, calendar, familiar objects, consistent caregivers
- Sleep promotion: Minimize nighttime interruptions, reduce noise and light
- Sensory optimization: Ensure glasses and hearing aids are available and in use
- Mobility: Early mobilization, physical therapy involvement
- Hydration and nutrition: Ensure adequate oral intake; avoid intravenous lines if possible
- Family involvement: Encourage family presence; educate about delirium
- Avoid restraints: Physical restraints worsen delirium and should be avoided
- Remove unnecessary devices: Catheters, telemetry, intravenous lines if not needed
Pharmacological Management (When Necessary)
| Scenario | First-Line Agent | Dose | Notes |
|---|---|---|---|
| Agitation threatening safety | Haloperidol | 0.5-2 mg PO, IM, or IV; repeat every 30-60 minutes as needed | Check QTc before and during use; avoid in Parkinson disease and Lewy body dementia |
| Elderly or high risk for extrapyramidal symptoms | Quetiapine | 12.5-50 mg PO; can repeat | More sedating; fewer extrapyramidal symptoms; avoid in Parkinson disease |
| Parkinson disease or Lewy body dementia | Quetiapine (cautiously) | 12.5-25 mg PO | Antipsychotics can worsen parkinsonism; use lowest effective dose for shortest time |
| Alcohol withdrawal | Benzodiazepines (lorazepam, diazepam) | Symptom-triggered dosing per CIWA-Ar protocol | Antipsychotics alone are contraindicated; lower seizure threshold |
| Benzodiazepine or sedative withdrawal | Benzodiazepines | Dose depends on prior use; taper gradually | May require prolonged taper; seizure risk if undertreated |
| Severe refractory agitation in intensive care | Dexmedetomidine | 0.2-1.5 mcg/kg/hour infusion | Alpha-2 agonist; may reduce delirium duration; monitor for bradycardia and hypotension |
Avoid These Medications in Delirium
- Benzodiazepines (unless treating withdrawal) — can worsen or prolong delirium
- Diphenhydramine — anticholinergic; commonly used for sleep but worsens delirium
- Meperidine — neurotoxic metabolite; high anticholinergic burden
- Long-acting sedatives — accumulate and prolong confusion
Disposition Considerations
| Patient Status | Recommended Disposition | Key Considerations |
|---|---|---|
| Delirium with unstable vital signs or serious underlying cause | Intensive care unit or step-down unit | Close monitoring; may need invasive monitoring or interventions |
| Delirium with stable vital signs, cause being treated | Medical ward with delirium precautions | 1:1 observation if needed; non-pharmacological interventions; frequent reassessment |
| Resolving delirium, medically stable | Continue current level of care until resolution | Ensure cause fully treated; assess for post-delirium cognitive impairment |
| Resolved delirium, ready for discharge | Home with follow-up | Family education; medication reconciliation; outpatient cognitive assessment if prolonged delirium |
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Critical Pitfalls to Avoid
Key Takeaways
- Delirium is defined by acute onset, fluctuating course, inattention, and either disorganized thinking or altered level of consciousness — use the Confusion Assessment Method (CAM) to diagnose.
- The three psychomotor subtypes are hyperactive (25%), hypoactive (25-50%), and mixed (35-45%). Hypoactive delirium is most commonly missed and has the worst prognosis.
- Use the “I WATCH DEATH” mnemonic to systematically consider all causes: Infection, Withdrawal, Acute metabolic, Trauma, CNS pathology, Hypoxia, Deficiencies, Endocrinopathies, Acute vascular, Toxins/drugs, Heavy metals and other.
- Collateral history from family, caregivers, or staff is essential — the delirious patient cannot provide reliable information about baseline cognition or recent changes.
- Baseline investigations for all patients include complete blood count, basic metabolic panel, urinalysis, chest radiograph, electrocardiogram, and point-of-care glucose.
- Neuroimaging is indicated urgently for focal neurological deficits, declining consciousness, recent head trauma, or anticoagulation — but a normal CT does not exclude all causes.
- Non-pharmacological management (reorientation, sleep hygiene, mobility, sensory aids, family involvement) is first-line for all patients and reduces delirium duration.
- Avoid benzodiazepines (except for withdrawal), anticholinergic medications, and physical restraints — these worsen delirium.
- When pharmacotherapy is needed for agitation, use low-dose haloperidol (0.5-2 mg) or quetiapine (12.5-50 mg). Avoid antipsychotics in Parkinson disease and Lewy body dementia if possible.
- Multiple causes are usually present — finding one precipitant should intensify the search for others, not end the workup.
- Delirium has serious long-term consequences including prolonged hospitalization, increased mortality, and accelerated cognitive decline. Prevention and early treatment are critical.
- In elderly patients, delirium may be the only presenting sign of serious illness such as myocardial infarction, pulmonary embolism, or sepsis — maintain high clinical suspicion.
Quick Reference Algorithm
Systematic Approach to Confusion and Delirium:
- Recognize: Suspect delirium in any patient with acute change in mental status — confirm with CAM (acute onset, fluctuating course, inattention, plus disorganized thinking or altered consciousness).
- Stabilize: Ensure airway, breathing, circulation. Check blood glucose immediately. Give thiamine before glucose if Wernicke encephalopathy is possible.
- Investigate: Obtain baseline labs (complete blood count, metabolic panel, urinalysis, chest radiograph, electrocardiogram). Order targeted tests based on clinical findings. CT head if focal signs, trauma, or anticoagulation.
- Review medications: Stop or reduce anticholinergics, sedatives, opioids, and other high-risk medications. Calculate anticholinergic burden.
- Identify and treat underlying cause(s): Remember that multiple causes are common. Treat infections, correct metabolic abnormalities, relieve urinary retention and fecal impaction, address pain.
- Implement non-pharmacological interventions: Reorientation, sleep promotion, mobility, sensory optimization, family involvement. These are first-line for all patients.
- Use pharmacotherapy judiciously: Reserve for patients whose agitation threatens safety. Low-dose antipsychotics preferred (except use benzodiazepines for alcohol and sedative withdrawal).
- Monitor and reassess: Delirium should improve as underlying causes are treated. If not improving, expand workup (MRI, lumbar puncture, EEG) and re-review medications.
- Prevent complications: Fall precautions, avoid restraints, pressure ulcer prevention, deep vein thrombosis prophylaxis, aspiration precautions.
- Plan for recovery: Educate family about delirium and prognosis. Arrange appropriate follow-up. Consider cognitive assessment after discharge if prolonged delirium.